It's Wednesday, November 18th, the welcome to market foolery. I'm Chris Hill with me today,

the one and only, Ron Gross. Good to see you, sir.

You too, how are you? I'm doing all right.

We've got more retail earnings to get to,

but we're gonna start with a vaccine update.

Pfizer and Bioantec said the final data analysis

on their COVID-19 vaccine found to be 95% effective.

So one more bit of good news on that front, they're planning to submit it to the FDA for final approval

within days.

The submission will be within days.

I think we're all hoping and expecting

that final approval comes maybe sometime later in December.

And you know, we're, maybe we're jaded now as investors after 10 days of this. We're not seeing the wild swings that

we saw a week ago Monday when the initial data came out but we are seeing some movement in the cruise line stocks although it's just not it's

just not necessarily what we saw a week ago Monday in particular carnival cruise lines appears to be having a busy day

they're canceling all of their cruises through the end of at least through the end of

January and yeah plus they have a secondary offering coming.

Exactly. There's a lot to unpack there, but I agree. We're kind of a little bit jaded. We're all vaccine experts now at least when it comes to the stock market.

And so I don't think the huge price swings will happen but this is exciting news I mean

We got it we got to get back to some kind of normal and and every time Pfizer or Moderna or J and J says something it gets exciting and in this

particular case 95% matching the Moderna news great Pfizer says the vaccine is highly effective against the virus 28 days

after the first dose.

...